Corbus Pharmaceuticals Holdings (CRBP) Market Capitalization (2014 - 2025)

Corbus Pharmaceuticals Holdings has reported Market Capitalization for 12 years, with the latest figure at $102.0 million in Q4 2025.

• On a quarterly basis, Market Capitalization fell 29.0% year-over-year to $102.0 million in Q4 2025; TTM through Dec 2025 was $102.0 million, a 29.0% decrease from a year earlier, with the FY2025 full-year figure at $99.1 million, down 31.02% from the prior year.
• Market Capitalization was $102.0 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $158.6 million in the prior quarter.
• The five-year high for Market Capitalization was $7.4 billion in Q1 2021, with the low at $13.8 million in Q4 2022.
• Average Market Capitalization over 5 years is $1.3 billion, with a median of $204.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Market Capitalization tumbled 99.4% in 2022, then surged 1400.61% in 2024.
• Over 5 years, Market Capitalization stood at $2.3 billion in 2021, then sank by 99.4% to $13.8 million in 2022, then surged by 93.23% to $26.7 million in 2023, then soared by 437.89% to $143.7 million in 2024, then slipped by 29.0% to $102.0 million in 2025.
• The last three Market Capitalization figures came in at $102.0 million (Q4 2025), $158.6 million (Q3 2025), and $84.6 million (Q2 2025), per Business Quant data.